| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 764191 | 1231772002 | ELUCIREM 0,5 MMOL/ML SOLUCION INYECTABLE | ELUCIREM 0,5 MMOL/ML SOLUCION INYECTABLE, 1 vial de 10 ml | 0,5 mmol/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231772002/1231772002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231772002/1231772002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44760 | LABORATORIOS FARMACEUTICOS GUERBET S.A. | 2024-02-05 | 1 | 1 | 1 | 2024-02-06 | 2024-02-05 | 1 | 2024-11-14 | View Edit Delete | ||||||||||||
| 765474 | 1231758001 | TEVIMBRA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | TEVIMBRA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 100 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231758001/1231758001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231758001/1231758001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71307 | BEONE MEDICINES ESP S.L. | 2024-07-26 | 1 | 1 | 1 | 2024-07-27 | 2024-07-26 | 1 | 2024-12-11 | View Edit Delete | ||||||||||||
| 767503 | 1241870001 | HETRONIFLY 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | HETRONIFLY 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241870001/1241870001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241870001/1241870001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2025-04-22 | 1 | 1 | 1 | 2025-04-23 | 2025-04-22 | 1 | 2026-01-13 | View Edit Delete | ||||||||||||
| 768285 | 1211538001IP | JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 500 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211538001IP/1211538001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211538001IP/1211538001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30289 | ABACUS MEDICINE A/S | 2025-08-08 | 1 | 1 | 1 | 2025-08-09 | 2025-08-08 | 1 | 2025-10-30 | View Edit Delete | ||||||||||||
| 767311 | 1241896001 | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241896001/1241896001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241896001/1241896001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | CELLTRION FARMACÉUTICA (ESPAÑA) S.L. | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 768383 | 1201497002IP1 | PHESGO 600 MG/600 MG SOLUCION INYECTABLE | PHESGO 600 MG/600 MG SOLUCION INYECTABLE, 1 vial de 10 ml | 600 mg/600 mg | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201497002IP1/1201497002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201497002IP1/1201497002IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ORIFARM A/S | 2025-08-29 | 1 | 1 | 1 | 2025-08-30 | 2025-08-29 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 768402 | 1151014002IP2 | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP2/1151014002IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP2/1151014002IP2_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | ORIFARM A/S | 2025-09-03 | 1 | 1 | 1 | 2025-09-04 | 2025-09-03 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 767479 | 1211594002 | RYBREVANT 1600 MG SOLUCION INYECTABLE | RYBREVANT 1600 MG SOLUCION INYECTABLE, 1 vial de 10 ml | 1600 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211594002/1211594002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211594002/1211594002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2025-04-14 | 1 | 1 | 1 | 2025-04-15 | 2025-04-14 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 775932 | 02233003 | INSULATARD 100 UI/ml SUSPENSION INYECTABLE EN VIAL | INSULATARD 100 UI/ml SUSPENSION INYECTABLE EN VIAL 1 vial de 10 ml | 100 U/ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02233003/02233003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02233003/02233003_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2003-08-05 | 1 | 1 | 1 | 2003-08-05 | 2003-08-05 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 776468 | 02231003 | MIXTARD 30 100 UI/ml SUSPENSION INYECTABLE EN VIAL | MIXTARD 30 100 UI/ml SUSPENSION INYECTABLE EN VIAL, 1 vial de 10 ml | 100 UI/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02231003/02231003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02231003/02231003_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2003-08-05 | 1 | 1 | 1 | 2003-08-05 | 2003-08-05 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 776211 | 47034 | KETOLAR 50 mg/ml SOLUCION INYECTABLE | KETOLAR 50 mg/ml SOLUCION INYECTABLE , 1 vial de 10 ml | 50 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/47034/47034_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/47034/47034_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 1968-12-01 | 1 | 1 | 1 | 1968-12-01 | 1968-12-01 | 0 | 2011-10-27 | Lista IV | View Edit Delete | |||||||||||
| 794958 | 64945 | PAMIDRONATO HOSPIRA 3 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | PAMIDRONATO HOSPIRA 3 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 10 ml | 30 mg | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64945/64945_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64945/64945_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 2002-07-26 | 1 | 1 | 1 | 2002-07-26 | 2002-07-26 | 1 | 2011-09-02 | View Edit Delete | ||||||||||||
| 819938 | 62759 | GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 10 ml | 20 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62759/62759_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62759/62759_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15233 | NEOVII BIOTECH GMBH | 1999-10-21 | 1 | 1 | 1 | 1999-10-21 | 1999-10-21 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 831453 | 00134012 | LANTUS 100 UNIDADES/ML SOLUCION INYECTABLE EN UN VIAL | LANTUS 100 UNIDADES/ML SOLUCION INYECTABLE EN UN VIAL, 1 vial de 10 ml | 100 U/ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00134012/00134012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00134012/00134012_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42153 | SANOFI AVENTIS S.A. | 2002-03-25 | 1 | 1 | 1 | 2002-03-25 | 2002-03-25 | 1 | 2011-06-21 | View Edit Delete | ||||||||||||
| 795328 | 64946 | PAMIDRONATO HOSPIRA 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | PAMIDRONATO HOSPIRA 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 10 ml | 60 mg | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64946/64946_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64946/64946_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 2002-07-26 | 1 | 1 | 1 | 2002-07-26 | 2002-07-26 | 1 | 2011-09-02 | View Edit Delete | ||||||||||||
| 795401 | 64947 | PAMIDRONATO HOSPIRA 9 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | PAMIDRONATO HOSPIRA 9 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 90 mg | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64947/64947_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64947/64947_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 2002-07-26 | 1 | 1 | 1 | 2002-07-26 | 2002-07-26 | 1 | 2011-09-02 | View Edit Delete | ||||||||||||
| 731063 | 1151076002 | KOVALTRY 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa de 2,5 ml (capacidad de 5 ml) | 250 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa de 2,5 ml (capacidad de 5 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076002/1151076002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076002/1151076002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2021-05-26 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 731061 | 1151076004 | KOVALTRY 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 500 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076004/1151076004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076004/1151076004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2021-05-26 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 731062 | 1151076006 | KOVALTRY 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 1.000 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa precargada de 2,5 ml (capacidad de 5 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076006/1151076006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076006/1151076006_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2021-05-26 | 1 | 2024-01-11 | View Edit Delete | ||||||||||||
| 710303 | 1151076008 | KOVALTRY 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | KOVALTRY 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 10 ml + 1 jeringa precargada de 5 ml | 2000 UI | 80 | 1 | 34 | 1 vial de 10 ml + 1 jeringa precargada de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151076008/1151076008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151076008/1151076008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2016-03-11 | 1 | 1 | 1 | 2016-03-11 | 2016-03-11 | 1 | 2016-10-10 | View Edit Delete |
Page 188 of 1035, showing 20 records out of 20697 total, starting on record 3741, ending on 3760